Kinetic Engineering Ltd. - Interim / Quarterly Report 2021

==> picture [552 x 112] intentionally omitted <==

Date: 15th November, 2021

The Manager - Corporate Relationship Department BSE Limited, 1st Floor, Phiroze Jeejeebhoy Towers, Fort, Mumbai- 400 001 Maharashtra, India

Scrip Code: BSE-500240

Subject: Unaudited Financial Results - Newspaper Publication.

Dear Sir/Madam,

Pursuant to the provisions of Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith newspaper advertisement published in Financial Express and Loksatta, both dated 14th November, 2021 for Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2021.

This is for your information and records.

Thanking You,

Yours Truly,

For Kinetic Engineering Limited

==> picture [68 x 68] intentionally omitted <==

==> picture [94 x 42] intentionally omitted <==

Kamlesh M Shinde Company Secretary and Compliance Officer

==> picture [489 x 13] intentionally omitted <==

WWW.FINANCIALEXPRESS.COM

SUNDAY, NOVEMBER 14, 2021

GLITTEK GRANITES LIMITED

==> picture [53 x 4] intentionally omitted <==

----- Start of picture text -----

CIN No.: L14102KA1990PLC023497
----- End of picture text -----

==> picture [83 x 5] intentionally omitted <==

----- Start of picture text -----

Regd. Office: 42, KIADB Industrial Area, Hoskote - 562 114.
----- End of picture text -----

==> picture [180 x 148] intentionally omitted <==

----- Start of picture text -----

Pentokey Organy (India) Ltd.CIN: L24116MH1986PLC041681
509, Western Edge I, O� Western Express Highway, Boriwali East, Mumbai - 400 066.
Tel. No. (91-22) 28545118 email: [email protected] www.pentokey.com
UNAUDITED STATEMENT OF FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH SEPTEMBER, 2021
` in Lakhs
Sr. Par�culars Quarter Ended Quarter Ended Year Ended
No. 30.09.2021 30.09.2020 31.03.2021
Unaudited Unaudited Audited
1 Total Revenue 5.43 5.70 29.98
2 Net Pro�t / (Loss) from ordinary ac�vi�es before Tax and Excep�onal Items (6.19) (8.40) (24.06)
3 Net Pro�t / (Loss) for the period a�er tax (A�er Excep�onal Items) (6.19) (8.40) (24.06)
4 Total Comprehensive Income for the period (6.02) (8.37) (23.22)
5 Equity Share Capital 627.26 627.26 627.26
6 Other Equity (Reserves excluding Revalua�on Reserve) (109.92) (103.90) (91.36)
7 Earnings per equity share (for con�nuing opera�ons)
Basic: (0.10) (0.13) (0.38)
Diluted: (0.10) (0.13) (0.38)
Notes:
The above is an extract of the detailed format of theExchanges under Regula�on 33 of the SEBI (Lis�ng �andnancial results for the Quarter ended 30th September, 2021Other Disclosure Requirements) Regula�ons, 2015. The�led with the Stockfull format of the
Quarter ended 30th September, 2021 are available on the Stock Exchange website, www.bseindia.com and the Company’s website
www.pentokey.com
For Pentokey Organy (India) Limited
SD/-
Pursho�am Kejriwal
Place : Mumbai Director
Date : 13th November, 2021 DIN : 02476745
----- End of picture text -----

==> picture [123 x 118] intentionally omitted <==

----- Start of picture text -----

(Amount . in Lakhs) Quarter Half Year Quarter Year to date Sl.No. Particulars (Unaudited)30.09.2021ended (Unaudited)30.09.2021ended (Unaudited)30.09.2020ended the previousyear ended31.03.2021figures for (Audited) 1. Total income from operations (Net) 234.58 375.65 440.51 1458.71 2. Net Profit/(Loss) from ordinary activities after tax -129.65 -237.57 -57.37 -309.64 3. Net Profit / (Loss) for the period after tax (after Extraordinary items) -129.65 -237.57 -57.37 -309.64 4. Equity Share Capital 1329.08 1329.08 1329.08 1329.08 5. Reserves (excluding Revaluation Reserve as shown in the Balance Sheet of previous year) 0.00 0.00 0.00 0.00 6. Earnings Per Share (before extraordinary items) (of 5/- each)
Basic : -0.50 -0.92 -0.22 -1.19
Diluted : -0.50 -0.92 -0.22 -1.19
7. Earnings Per Share (after extraordinary items)
(of ` 5/- each)
Basic : -0.50 -0.92 -0.22 -1.19
Diluted : -0.50 -0.92 -0.22 -1.19
Note: The above is an extract of the detailed format of Quarterly/Annual Financial Results filed with theStock Exchanges under Regulation 33 of the SEBI (Listing and Other Disclosure Requirements)
Regulations, 2015. The full format of the Quarterly/Annual Financial Results are available on the Stock
Exchangewebsites www.bseindia.com andtheCompany'swebsite www.glittek.com
By Order of the Board
For Glittek Granites Ltd.
Place: Hoskote Ashoke Agarwal
Date: 13th November, 2021 Joint Managing Director
----- End of picture text -----

==> picture [184 x 103] intentionally omitted <==

----- Start of picture text -----

MESCO PHARMACEUTICALS LTD
CIN: L24111UR1986PLC015895
Regd.Office : UPPER KESALTION TALLITAL NANITAL UR 263001
Website:www. Mescopharma.com.,Tel: 011-41587085, Email: [email protected]
Extract of Audited Standalone Financial Results for the Quarter Ended September 30, 2021
(Figuresin Rs.)
Quarter ended Half Year Ended Year ended
Particulars 30.09.2021 30.06.2021 30.09.2020 30.09.2021 30.09.2020 31.03.2021
(Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited)
Total Income from Operations - - - - - -
Net Profit / (Loss) for the period (before Tax, Exceptional
and/or Extraordinary items) (5,030) (5,030) (6,030) (10,060) (12,030) (39,061)
Net Profit / (Loss) for the period before tax (after Exceptional
and/or Extraordinary items) (5,030) (5,030) (6,030) (10,060) (12,030) (39,061)
Net Profit / (Loss) for the period after tax (after Exceptional
and/or Extraordinary items) (5,030) (5,030) (6,030) (10,060) (12,030) (39,061)
Total Comprehensive Income for the period [Comprising
Profit/(Loss) for the period (after tax) and Other Comprehensive
Income (after tax)] (5,030) (5,030) (6,030) (10,060) (12,030) (39,061)
Paid up Equity Share Capital
(Face value Rs.10/- per Equity Share ) 197,381,000 197,381,000 197,381,000 197,381,000 197,381,000 197,381,000
Reserves (excluding Revaluation Reserve) as shown in the
Audited Balance Sheet of the previous year (307,553,360)
Earnings Per Share (of Rs. 10/- each) (for continuing and
discontinued operations): Basic and Diluted (0.00) 0.00 (0.00) (0.00) (0.00) (0.00)
----- End of picture text -----

Notes: 1) The above is an extract of the detailed format of the standalone financial Results for the quarter ended September 30, 2021 filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The full format of the Financial Results for the quarter ended September 30, 2021 is available on the Stock Exchanges’ website www.bseindia.com and Company’s website www.mescopharma.com
2) The Statutory Auditors of the Company have carried out Limited Review of the above Results. 3) The above audited financial results for the quarter and year ended on September 30, 2021 have been reviewed by the Audit Committee and have been approved by the Board of Directors in its meeting held on 12.11.2021
4) Previous year period figures have been rearranged and regrouped wherever necessary to make them comparable with current period figures. 5) There were no manufacturing activities in the Company during the period under consideration

Forand on Behalf of Board of Directors of MescoPharmaceuticals Limited Sd/Dhruv Singh Place: New Delhi Director & CEO Date : 12.11.2021 DIN 2983286

Pune

�� 

��

�� ��  �� ��  �� �� �� ��  �� � � �� � � �� � �� �� � � �� �� �� � � �� � � � �� � � �� � � �� � �� �� �� �� � � �� �� �� ��  �� �� �� � � �� ��  �� ��  �� � � �� �� �� ��  �� ��  �� � �� �� �� �� � �� � �� �� �� �� �� �� �� �� �� �� �� �� ��  �� � � �� � � �� ��  �� � � �� ��  �� �� �� �� �� � �� �� � � �� � � �� �� ��

AI assistant

Kinetic Engineering Ltd. Interim / Quarterly Report 2021

60836_rns_2021-11-15_af7bdf71-eb72-4f90-b755-0ebb505d9eff.pdf

For Kinetic Engineering Limited

GLITTEK GRANITES LIMITED

AI assistant

Kinetic Engineering Ltd. — Interim / Quarterly Report 2021

60836_rns_2021-11-15_af7bdf71-eb72-4f90-b755-0ebb505d9eff.pdf

For Kinetic Engineering Limited

GLITTEK GRANITES LIMITED

More from Kinetic Engineering Ltd.

Kinetic Engineering Ltd. Interim / Quarterly Report 2021